Literature DB >> 22721923

Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats.

Lucas C Pinheiro1, Marcelo F Montenegro, Jefferson H Amaral, Graziele C Ferreira, Alisson M Oliveira, Jose E Tanus-Santos.   

Abstract

The new pathway nitrate-nitrite-nitric oxide (NO) has emerged as a physiological alternative to the classical enzymatic pathway for NO formation from l-arginine. Nitrate is converted to nitrite by commensal bacteria in the oral cavity and the nitrite formed is then swallowed and reduced to NO under the acidic conditions of the stomach. In this study, we tested the hypothesis that increases in gastric pH caused by omeprazole could decrease the hypotensive effect of oral sodium nitrite. We assessed the effects of omeprazole treatment on the acute hypotensive effects produced by sodium nitrite in normotensive and L-NAME-hypertensive free-moving rats. In addition, we assessed the changes in gastric pH and plasma levels of nitrite, NO(x) (nitrate+nitrite), and S-nitrosothiols caused by treatments. We found that the increases in gastric pH induced by omeprazole significantly reduced the hypotensive effects of sodium nitrite in both normotensive and L-NAME-hypertensive rats. This effect of omeprazole was associated with no significant differences in plasma nitrite, NO(x), or S-nitrosothiol levels. Our results suggest that part of the hypotensive effects of oral sodium nitrite may be due to its conversion to NO in the acidified environment of the stomach. The increase in gastric pH induced by treatment with omeprazole blunts part of the beneficial cardiovascular effects of dietary nitrate and nitrite.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721923     DOI: 10.1016/j.freeradbiomed.2012.06.001

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  24 in total

1.  Proton pump inhibitors and nitric oxide mechanisms in type 2 diabetes.

Authors:  Jonas T C Sertorio
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

Review 2.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health.

Authors:  Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris
Journal:  Free Radic Biol Med       Date:  2016-12-16       Impact factor: 7.376

3.  Differential effect of beetroot bread on postprandial DBP according to Glu298Asp polymorphism in the eNOS gene: a pilot study.

Authors:  D A Hobbs; T W George; J A Lovegrove
Journal:  J Hum Hypertens       Date:  2014-03-27       Impact factor: 3.012

4.  Acid Test for Nitrite Pharmacology.

Authors:  Barbora Piknova; Alan N Schechter
Journal:  Hypertension       Date:  2016-10-31       Impact factor: 10.190

Review 5.  Functional Nitric Oxide Nutrition to Combat Cardiovascular Disease.

Authors:  Nathan S Bryan
Journal:  Curr Atheroscler Rep       Date:  2018-03-17       Impact factor: 5.113

6.  Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension.

Authors:  Marcelo F Montenegro; Lucas C Pinheiro; Jefferson H Amaral; Graziele C Ferreira; Rafael L Portella; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06       Impact factor: 3.000

7.  Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin.

Authors:  Cesar A Meschiari; Lucas C Pinheiro; Danielle A Guimaraes; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-28       Impact factor: 3.000

Review 8.  The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction.

Authors:  Julio A Chirinos; Payman Zamani
Journal:  Curr Heart Fail Rep       Date:  2016-02

Review 9.  Strategies to increase nitric oxide signalling in cardiovascular disease.

Authors:  Jon O Lundberg; Mark T Gladwin; Eddie Weitzberg
Journal:  Nat Rev Drug Discov       Date:  2015-08-07       Impact factor: 84.694

Review 10.  How May Proton Pump Inhibitors Impair Cardiovascular Health?

Authors:  Roman A Sukhovershin; John P Cooke
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.